The secretion of esRAGE and the maturation of cRAGE from membrane-bound fl-RAGE likely play an important role in attenuating RAGE signaling and reducing the inflammatory response in gliomas, suggesting that potential strategies to limit their production may have therapeutic benefit against GBM. The gene discussed is AGER; the disease is central nervous system cancer.